25,000㎡
World's Largest Independently Owned Swiftlet Farm
Located in the BIO DESARU VALLEY in Johor, Malaysia, with bird's nest sourced 100% from our own farm and an average sialic acid content of 10%.
About Us · ABOUT GLYKEN
GLYKEN is a Singapore-born, fourth-generation low-molecular-weight bird's nest peptide brand. For 16 years we have built the entire bird's nest value chain end to end — from a single proprietary swiftlet farm to a single extraction patent — so that more people can access more precise nourishment in a simpler way.
Our Story · OUR STORY
Because I have known pain, I never want you to feel it again
Most people know us as a husband-and-wife founding team. What few know is that GLYKEN began with pain. In 2019, my husband suffered from chronic insomnia and night sweats — and hardest of all, a lower-back pain that never let up, day or night. The doctors offered a hormone regimen, but we wanted something gentler, something we could rely on for the long term to bring his body back into balance.
Stranded in Singapore during the pandemic, he searched everywhere for an answer. By chance, we discovered GLYKEN bird's nest peptide — Singapore-born and built on more than a decade of bird's nest expertise. After just three days, my pain was gone, and it has never returned. In that moment I made a decision: not simply to use it, but to bring it home to China. My husband invested RMB 50 million to transfer the technology across borders and establish production at home.
We believe that what is truly good should not belong only to a privileged few. GLYKEN is more than a product — it is a way of using science to renew the value of life, helping people access more precise nutrition in a simpler way.
Strength You Can See · OUR STRENGTH
From our own swiftlet farm in Malaysia to Asia's largest extraction facility, GLYKEN is a fully integrated group spanning the research, development, production, and sale of bird's nest nutrition.
Located in the BIO DESARU VALLEY in Johor, Malaysia, with bird's nest sourced 100% from our own farm and an average sialic acid content of 10%.
We brought our complete high-temperature charge-coupled extraction patent production line to China, delivering low-molecular-weight active bird's nest peptide at consistent, industrial scale.
Opened in Shenzhen in 2021 to share bird's nest culture and fourth-generation science-driven bird's nest.
In 2020, GLYKEN established its operations in the China-Malaysia Qinzhou Industrial Park — a cross-border industrial project jointly built by the Chinese and Malaysian governments under the Belt and Road framework — investing tens of millions of yuan to set up its processing base in China.
Science & Trust · SCIENCE & TRUST
Using our patented high-temperature charge-coupled extraction technology (non-enzymatic), we extract the 18 amino acids, sialic acid, and active factors such as EGF and CSF from bird's nest into low-molecular-weight glycoprotein peptides the body can absorb directly.
Five research leaders, headed by Chief Scientist Dr. Kien Hui Chua, drawing on four research centers: NUS, UKM, South China University of Technology, and Malaysia University of Science and Technology.
Our Journey · MILESTONES
The GLYKEN Group is established in Singapore, building deep expertise across the entire bird's nest value chain.
Multiple studies on bird's nest extracts are presented at the TERMIS-AP annual meeting of the International Society for Tissue Engineering and Regenerative Medicine.
Joint R&D with NUS and other universities advances research into low-molecular-weight bird's nest peptide.
GLYKEN establishes operations in the China-Malaysia Qinzhou Industrial Park, investing tens of millions of yuan in a production facility and founding Kelaikang Bird's Nest Technology (Shenzhen).
The Greater Bay Area's first bird's nest experience center opens in Shenzhen.
Together with the China National Food Industry Association, GLYKEN initiates the Bird's Nest Peptide industry standard and is recognized as a principal drafting unit.
The T/CNFIA 172-2023 Bird's Nest Peptide group standard is officially released.
The GLYKEN Group is established in Singapore, building deep expertise across the entire bird's nest value chain.
Multiple studies on bird's nest extracts are presented at the TERMIS-AP annual meeting of the International Society for Tissue Engineering and Regenerative Medicine.
Joint R&D with NUS and other universities advances research into low-molecular-weight bird's nest peptide.
GLYKEN establishes operations in the China-Malaysia Qinzhou Industrial Park, investing tens of millions of yuan in a production facility and founding Kelaikang Bird's Nest Technology (Shenzhen).
The Greater Bay Area's first bird's nest experience center opens in Shenzhen.
Together with the China National Food Industry Association, GLYKEN initiates the Bird's Nest Peptide industry standard and is recognized as a principal drafting unit.
The T/CNFIA 172-2023 Bird's Nest Peptide group standard is officially released.
LET'S TALK
Whether you're a consumer seeking premium nutrition or an institution looking for a long-term partner, GLYKEN is ready to bring molecular-grade bird's nest to more people — with you.